Skip to main content
. 2023 Jan 20;54(1):186–191. [Article in Chinese] doi: 10.12182/20230160111

表 2. Comparison of serum indicators in each group.

各组血清指标对比

Group n PGⅠ/(μg/L) PGⅡ/(μg/L) PGⅠ/PGⅡ CEA/(ng/mL) CA199/(U/mL) CA724/(U/mL)
 a P<0.05, vs. healthy group; b P<0.05, vs. benign group; c P<0.05, vs. low grade group; d P<0.05, vs. high grade group.
Healthy 104 135.64±21.38 12.06±2.51 11.25±2.06 2.89±0.57 11.49±2.23 3.17±0.63
Benign 115 115.43±20.71a 13.49±2.68 8.57±1.58a 3.04±0.60 12.06±2.35 3.32±0.66
Low grade 112 103.29±20.12a, b 14.81±2.37a, b 6.97±1.24a, b 6.72.±1.39a, b 23.58±4.39a, b 7.19±1.32a, b
High grade 109 91.48±20.23a, b, c 15.96±2.45a, b, c 5.73±1.16a, b, c 8.45±1.64a, b, c 27.87±5.26a, b, c 8.85±1.57a, b, c
Gastric cancer 109 57.86±8.33a, b, c, d 27.52±5.37a, b, c, d 2.10±0.41a, b, c, d 69.72±11.46a, b, c, d 126.47±24.38a, b, c, d 65.08±10.57a, b, c, d
F 4189.499 3976.748 4008.428 5016.006 3709.426 5316.842
P 0.000 0.000 0.000 0.000 0.000 0.000